RELAY THERAPEUTICS INC (RLAY)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About RELAY THERAPEUTICS INC
Relay Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops small molecule therapies for cancer and genetic conditions through a precision-medicine approach and clinical trials. In FY2025, Relay Therapeutics generated $15.4 million in revenue. The company, formerly known as Allostery, Inc., is based in Cambridge, Massachusetts, was founded in 2015, and went public in 2020.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
RELAY THERAPEUTICS INC's Technical Indicators Summary
RLAY exhibits a solid bullish technical posture, with the shares trading near $19.94 and sitting above short- and longer-term moving averages that reflect clear price support. Momentum indicators such as a high CCI and a positive momentum reading bolster buying conviction, and ADX around 26 signals a meaningful trend. Volume trends are constructive as OBV is positive, while volatility is moderate with an ATR near $1.09 (about 5.5%), and the price is slightly above the classic pivot. Technical takeaway: trend strength, momentum, and supportive moving averages together justify the strong buy assessment.
| Indicator | Value |
|---|---|
RSI (14) | 60.54 |
Stochastic %K (14, 3, 3) | 77.08 |
CCI (20) | 143.42 |
WPR (14) | -25.67 |
Momentum (10) | 1.30 |
MFI | 56.35 |
MACD Level (12, 26) | 0.48 |
Bollinger Bands | $18.19 - $20.23 |
ATR (14) | $1.09 (5.46%) |
ADX (14) | 26.12 |
OBV | 118,322,563 |
Classic Pivot Point | $19.43 |
Fibonacci Pivot Point | $19.43 |
Exponential Moving Averages | $12.21 - $19.44(5 indicators) |
Simple Moving Averages | $11.74 - $19.24(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The last session saw a slight bid for RLAY, which crept 0.86% higher by the close. RLAY rises after Perceptive Advisors discloses a 6.4% stake in Relay Therapeutics.
Trading Volume
Above 10d avg 2.1M
2.6M
vs S&P 500 Today
Outperforming Market
+0.92%
52-Week Position
Near highs
95.2%
Updated: August 11, 2026 at 12:44 UTC